Stay updated with breaking news from Two biden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sen. Bob Menendez (D-N.J.), chairman of the Foreign Relations Committee, asked two Biden administration bureaucrats if they are exploring "potential paths" to get Poland's Soviet-era jets to Ukraine. Their answers were as clear as mud. ....
April 20, 20213:47 AM UTC United StatesBiden administration strikes deal to offer 22,000 extra seasonal guestworker visas - Bloomberg Law Reuters 2 minutes read Two Biden administration agencies have struck a deal to offer 22,000 extra seasonal guestworker visas to employers in the coming months, Bloomberg Law reported on Monday. Homeland Security Secretary Alejandro Mayorkas and Labor Secretary Marty Walsh agreed late last week to lift the cap on H-2B visas, the report said, citing two sources familiar with the process. The extra visas for seasonal non-agricultural labor, called the H-2B visas, are in addition to the annual allotment of 66,000 H-2B visas. ....
Biden administration strikes deal to offer 22,000 extra seasonal guest-worker visas mvariety.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mvariety.com Daily Mail and Mail on Sunday newspapers.
What to Know in Washington: Businesses to Reap Earmark Benefits bgov.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bgov.com Daily Mail and Mail on Sunday newspapers.
April 16, 2021 6:10 AM By Brandon Lee Lawmakers seeking to lower drug costs should take a comprehensive approach rather than focus solely on manufacturersâ pricing practicesâa strategy thatâs only created disparities in the marketplace, policy analysts say. Drug pricing will come back to the forefront of policy discussions in the coming months as Covid-19 vaccines become more readily available and lawmakers turn to other issues. But many of the roughly two dozen bills floating around Congress primarily address the prices drug companies set and ignore other aspects of the supply chain, including the pharmacy middlemen that control how insurance pays for medications. ....